Esomeprazole And Symptomatic Response In Patients With Or Without An Elevated Risk For Non-Steroidal Anti-Inflammatory Drug (NSAID)-Associated GI Damage

Inclusion Criteria

• •Patient with upper gastro-intestinal complaints (defined as heartburn and/or regurgitation and/or nausea and/or bloated feeling)and treatment with esomeprazole 20mg once daily is started because of this (consult 1). Upper gastro-intestinal complaints are thought to be related to NSAID use
• •Patient is using an NSAID\*\* with the following conditions:
• •* NSAID use has started at least one week before 1st consultation and is expected to be continued unchanged during the coming period (at least until consult 2)
• •* NSAID is taken at least 3 days a week
• •(\*\*)OTC or Prescription NSAID
• •(\*\*)Conventional NSAID or COX-2 selective NSAID